Bionano Genomics (BNGO) Return on Sales (2017 - 2026)

Bionano Genomics has disclosed Return on Sales across 10 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (up 2.0% YoY), and the FY2025 annual result was 0.01%, up 3.0% from the prior year.
• Return on Sales came in at 0.01% for Q1 2026 at Bionano Genomics, down from 0.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q1 2025 to a low of 0.12% in Q3 2023.
• The 5-year median for Return on Sales is 0.04% (2023), against an average of 0.04%.
• Across the five-year window, Return on Sales slipped 8 bps in 2023 and climbed 6 bps in 2025, its largest moves.
• Bionano Genomics' Return on Sales stood at 0.05% in 2022, then climbed by 13 bps to 0.04% in 2023, then surged by 38 bps to 0.03% in 2024, then soared by 60 bps to 0.01% in 2025, then slipped by 24 bps to 0.01% in 2026.
• The last three Return on Sales figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.